FLT1 and neoplasm: We first engineered lentiviruses to deplete Flt1 expression (“Flt1i”) in the tumor cells by CRISPR-mediated gene repression (CRISPRi) using two independent guide RNAs (“gRNA1” or “gRNA2”), as described previously (Biswas et al, 2022) (EV3E,F).